A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors

Clinical trial NCT04903873 · UNKNOWN

Trial details

NCT number: NCT04903873
Sponsor: Eutilex
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor Renal Cell Cancer Metastatic Non-Small Cell Lung Cancer Renal Cell Carcinoma Prostate Cancer

Start date: 2021-05-31
Primary completion: 2025-09-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.